The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Amantadine HCl Oral Market Research Report 2024

Global Amantadine HCl Oral Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1804413

No of Pages : 102

Ask Your Query
Synopsis
Amantadine is a medication that has U.S. Food and Drug Administration approval for use both as an antiviral and an antiparkinsonian medication.
The global Amantadine HCl Oral market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Amantadine HCl Oral is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Amantadine HCl Oral is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Amantadine HCl Oral include Zydus Pharmaceuticals, Mylan, Teva, Vertical Pharmaceuticals, Adamas Pharmaceuticals, Upsher-Smith, Sandoz, Mikart Pharmaceuticals and Pharmaceutical Associates, Inc. (PAI), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Amantadine HCl Oral, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amantadine HCl Oral.
Report Scope
The Amantadine HCl Oral market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amantadine HCl Oral market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amantadine HCl Oral manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zydus Pharmaceuticals
Mylan
Teva
Vertical Pharmaceuticals
Adamas Pharmaceuticals
Upsher-Smith
Sandoz
Mikart Pharmaceuticals
Pharmaceutical Associates, Inc. (PAI)
Wockhardt Bio AG
CMP Pharma
Bionpharma
Graviti Pharma
Alembic Pharmaceuticals
Strides Pharma
Heritage Pharmaceuticals
Segment by Type
Tablet
Capsules
Syrup
Segment by Application
Parkinson's Disease
Influenza
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amantadine HCl Oral manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amantadine HCl Oral in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Amantadine HCl Oral Market Overview
1.1 Product Overview and Scope of Amantadine HCl Oral
1.2 Amantadine HCl Oral Segment by Type
1.2.1 Global Amantadine HCl Oral Market Value Comparison by Type (2024-2030)
1.2.2 Tablet
1.2.3 Capsules
1.2.4 Syrup
1.3 Amantadine HCl Oral Segment by Application
1.3.1 Global Amantadine HCl Oral Market Value by Application: (2024-2030)
1.3.2 Parkinson's Disease
1.3.3 Influenza
1.4 Global Amantadine HCl Oral Market Size Estimates and Forecasts
1.4.1 Global Amantadine HCl Oral Revenue 2019-2030
1.4.2 Global Amantadine HCl Oral Sales 2019-2030
1.4.3 Global Amantadine HCl Oral Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Amantadine HCl Oral Market Competition by Manufacturers
2.1 Global Amantadine HCl Oral Sales Market Share by Manufacturers (2019-2024)
2.2 Global Amantadine HCl Oral Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Amantadine HCl Oral Average Price by Manufacturers (2019-2024)
2.4 Global Amantadine HCl Oral Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Amantadine HCl Oral, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amantadine HCl Oral, Product Type & Application
2.7 Amantadine HCl Oral Market Competitive Situation and Trends
2.7.1 Amantadine HCl Oral Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Amantadine HCl Oral Players Market Share by Revenue
2.7.3 Global Amantadine HCl Oral Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Amantadine HCl Oral Retrospective Market Scenario by Region
3.1 Global Amantadine HCl Oral Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Amantadine HCl Oral Global Amantadine HCl Oral Sales by Region: 2019-2030
3.2.1 Global Amantadine HCl Oral Sales by Region: 2019-2024
3.2.2 Global Amantadine HCl Oral Sales by Region: 2025-2030
3.3 Global Amantadine HCl Oral Global Amantadine HCl Oral Revenue by Region: 2019-2030
3.3.1 Global Amantadine HCl Oral Revenue by Region: 2019-2024
3.3.2 Global Amantadine HCl Oral Revenue by Region: 2025-2030
3.4 North America Amantadine HCl Oral Market Facts & Figures by Country
3.4.1 North America Amantadine HCl Oral Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Amantadine HCl Oral Sales by Country (2019-2030)
3.4.3 North America Amantadine HCl Oral Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Amantadine HCl Oral Market Facts & Figures by Country
3.5.1 Europe Amantadine HCl Oral Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Amantadine HCl Oral Sales by Country (2019-2030)
3.5.3 Europe Amantadine HCl Oral Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amantadine HCl Oral Market Facts & Figures by Country
3.6.1 Asia Pacific Amantadine HCl Oral Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Amantadine HCl Oral Sales by Country (2019-2030)
3.6.3 Asia Pacific Amantadine HCl Oral Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Amantadine HCl Oral Market Facts & Figures by Country
3.7.1 Latin America Amantadine HCl Oral Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Amantadine HCl Oral Sales by Country (2019-2030)
3.7.3 Latin America Amantadine HCl Oral Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Amantadine HCl Oral Market Facts & Figures by Country
3.8.1 Middle East and Africa Amantadine HCl Oral Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Amantadine HCl Oral Sales by Country (2019-2030)
3.8.3 Middle East and Africa Amantadine HCl Oral Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Amantadine HCl Oral Sales by Type (2019-2030)
4.1.1 Global Amantadine HCl Oral Sales by Type (2019-2024)
4.1.2 Global Amantadine HCl Oral Sales by Type (2025-2030)
4.1.3 Global Amantadine HCl Oral Sales Market Share by Type (2019-2030)
4.2 Global Amantadine HCl Oral Revenue by Type (2019-2030)
4.2.1 Global Amantadine HCl Oral Revenue by Type (2019-2024)
4.2.2 Global Amantadine HCl Oral Revenue by Type (2025-2030)
4.2.3 Global Amantadine HCl Oral Revenue Market Share by Type (2019-2030)
4.3 Global Amantadine HCl Oral Price by Type (2019-2030)
5 Segment by Application
5.1 Global Amantadine HCl Oral Sales by Application (2019-2030)
5.1.1 Global Amantadine HCl Oral Sales by Application (2019-2024)
5.1.2 Global Amantadine HCl Oral Sales by Application (2025-2030)
5.1.3 Global Amantadine HCl Oral Sales Market Share by Application (2019-2030)
5.2 Global Amantadine HCl Oral Revenue by Application (2019-2030)
5.2.1 Global Amantadine HCl Oral Revenue by Application (2019-2024)
5.2.2 Global Amantadine HCl Oral Revenue by Application (2025-2030)
5.2.3 Global Amantadine HCl Oral Revenue Market Share by Application (2019-2030)
5.3 Global Amantadine HCl Oral Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Zydus Pharmaceuticals
6.1.1 Zydus Pharmaceuticals Corporation Information
6.1.2 Zydus Pharmaceuticals Description and Business Overview
6.1.3 Zydus Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Zydus Pharmaceuticals Amantadine HCl Oral Product Portfolio
6.1.5 Zydus Pharmaceuticals Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Amantadine HCl Oral Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mylan Amantadine HCl Oral Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Amantadine HCl Oral Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Amantadine HCl Oral Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Vertical Pharmaceuticals
6.4.1 Vertical Pharmaceuticals Corporation Information
6.4.2 Vertical Pharmaceuticals Description and Business Overview
6.4.3 Vertical Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Vertical Pharmaceuticals Amantadine HCl Oral Product Portfolio
6.4.5 Vertical Pharmaceuticals Recent Developments/Updates
6.5 Adamas Pharmaceuticals
6.5.1 Adamas Pharmaceuticals Corporation Information
6.5.2 Adamas Pharmaceuticals Description and Business Overview
6.5.3 Adamas Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Adamas Pharmaceuticals Amantadine HCl Oral Product Portfolio
6.5.5 Adamas Pharmaceuticals Recent Developments/Updates
6.6 Upsher-Smith
6.6.1 Upsher-Smith Corporation Information
6.6.2 Upsher-Smith Description and Business Overview
6.6.3 Upsher-Smith Amantadine HCl Oral Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Upsher-Smith Amantadine HCl Oral Product Portfolio
6.6.5 Upsher-Smith Recent Developments/Updates
6.7 Sandoz
6.6.1 Sandoz Corporation Information
6.6.2 Sandoz Description and Business Overview
6.6.3 Sandoz Amantadine HCl Oral Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sandoz Amantadine HCl Oral Product Portfolio
6.7.5 Sandoz Recent Developments/Updates
6.8 Mikart Pharmaceuticals
6.8.1 Mikart Pharmaceuticals Corporation Information
6.8.2 Mikart Pharmaceuticals Description and Business Overview
6.8.3 Mikart Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mikart Pharmaceuticals Amantadine HCl Oral Product Portfolio
6.8.5 Mikart Pharmaceuticals Recent Developments/Updates
6.9 Pharmaceutical Associates, Inc. (PAI)
6.9.1 Pharmaceutical Associates, Inc. (PAI) Corporation Information
6.9.2 Pharmaceutical Associates, Inc. (PAI) Description and Business Overview
6.9.3 Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Product Portfolio
6.9.5 Pharmaceutical Associates, Inc. (PAI) Recent Developments/Updates
6.10 Wockhardt Bio AG
6.10.1 Wockhardt Bio AG Corporation Information
6.10.2 Wockhardt Bio AG Description and Business Overview
6.10.3 Wockhardt Bio AG Amantadine HCl Oral Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Wockhardt Bio AG Amantadine HCl Oral Product Portfolio
6.10.5 Wockhardt Bio AG Recent Developments/Updates
6.11 CMP Pharma
6.11.1 CMP Pharma Corporation Information
6.11.2 CMP Pharma Amantadine HCl Oral Description and Business Overview
6.11.3 CMP Pharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2019-2024)
6.11.4 CMP Pharma Amantadine HCl Oral Product Portfolio
6.11.5 CMP Pharma Recent Developments/Updates
6.12 Bionpharma
6.12.1 Bionpharma Corporation Information
6.12.2 Bionpharma Amantadine HCl Oral Description and Business Overview
6.12.3 Bionpharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Bionpharma Amantadine HCl Oral Product Portfolio
6.12.5 Bionpharma Recent Developments/Updates
6.13 Graviti Pharma
6.13.1 Graviti Pharma Corporation Information
6.13.2 Graviti Pharma Amantadine HCl Oral Description and Business Overview
6.13.3 Graviti Pharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Graviti Pharma Amantadine HCl Oral Product Portfolio
6.13.5 Graviti Pharma Recent Developments/Updates
6.14 Alembic Pharmaceuticals
6.14.1 Alembic Pharmaceuticals Corporation Information
6.14.2 Alembic Pharmaceuticals Amantadine HCl Oral Description and Business Overview
6.14.3 Alembic Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Alembic Pharmaceuticals Amantadine HCl Oral Product Portfolio
6.14.5 Alembic Pharmaceuticals Recent Developments/Updates
6.15 Strides Pharma
6.15.1 Strides Pharma Corporation Information
6.15.2 Strides Pharma Amantadine HCl Oral Description and Business Overview
6.15.3 Strides Pharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Strides Pharma Amantadine HCl Oral Product Portfolio
6.15.5 Strides Pharma Recent Developments/Updates
6.16 Heritage Pharmaceuticals
6.16.1 Heritage Pharmaceuticals Corporation Information
6.16.2 Heritage Pharmaceuticals Amantadine HCl Oral Description and Business Overview
6.16.3 Heritage Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Heritage Pharmaceuticals Amantadine HCl Oral Product Portfolio
6.16.5 Heritage Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amantadine HCl Oral Industry Chain Analysis
7.2 Amantadine HCl Oral Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amantadine HCl Oral Production Mode & Process
7.4 Amantadine HCl Oral Sales and Marketing
7.4.1 Amantadine HCl Oral Sales Channels
7.4.2 Amantadine HCl Oral Distributors
7.5 Amantadine HCl Oral Customers
8 Amantadine HCl Oral Market Dynamics
8.1 Amantadine HCl Oral Industry Trends
8.2 Amantadine HCl Oral Market Drivers
8.3 Amantadine HCl Oral Market Challenges
8.4 Amantadine HCl Oral Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock